Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
1,159.59
1,017.53
1,024.03
1,055.55
1,010.41
1,033.09
1,019.11
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,159.59
1,017.53
1,024.03
1,055.55
1,010.41
1,033.09
1,019.11
Raw Material Cost
611.26
552.63
547.90
623.85
564.60
505.67
559.50
Purchase of Finished goods
60.29
56.71
21.08
19.49
30.27
90.86
40.86
(Increase) / Decrease In Stocks
7.04
-16.77
12.94
-4.25
7.52
-0.57
-4.35
Employee Cost
189.38
189.27
176.14
183.90
175.60
180.10
176.22
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
-0.01
0.00
0.00
0.00
-0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
144.77
141.23
137.00
138.64
111.06
135.85
118.88
Total Expenditure (Excl Depreciation)
1,012.73
923.06
895.06
961.63
889.05
911.90
891.10
Operating Profit (PBDIT) excl Other Income
146.86
94.47
128.97
93.92
121.36
121.19
128.01
Other Income
34.33
32.37
26.73
17.55
14.56
13.47
6.55
Operating Profit (PBDIT)
181.19
126.84
155.70
111.47
135.92
134.66
134.56
Interest
23.74
23.30
23.14
4.54
5.13
11.90
13.02
Exceptional Items
-18.23
0.00
0.00
8.22
4.78
3.70
0.00
Gross Profit (PBDT)
139.22
103.54
132.56
115.15
135.57
126.46
121.54
Depreciation
39.65
37.86
36.92
40.00
44.52
34.87
34.06
Profit Before Tax
99.57
65.67
95.65
75.14
91.05
91.59
87.48
Tax
31.89
22.98
30.96
-74.47
24.74
24.94
26.27
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
67.67
42.70
64.69
149.61
66.31
66.65
61.21
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
67.67
42.70
64.69
149.61
66.31
66.65
61.21
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.36
1.91
1.21
1.99
1.13
1.45
1.04
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
66.32
40.78
63.48
147.62
65.18
65.21
60.17
Equity Capital
30.62
30.62
30.62
30.62
30.62
30.62
28.61
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
2,802.87
0.00
Earnings per share (EPS)
4.33
2.66
4.15
9.64
4.26
4.26
4.21
Diluted Earnings per share
4.33
2.66
4.15
9.64
4.26
4.37
4.21
Operating Profit Margin (Excl OI)
12.66%
9.28%
12.59%
8.9%
12.01%
11.73%
12.56%
Gross Profit Margin
12.01%
10.18%
12.94%
10.91%
13.42%
12.24%
11.93%
PAT Margin
5.84%
4.2%
6.32%
14.17%
6.56%
6.45%
6.01%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 13.96% vs -0.63% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 62.63% vs -35.76% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 55.46% vs -26.75% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is 1.89% vs 0.69% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
Compare Quarterly Results Of Akums Drugs With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
1,159.59
0
1,159.59
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,159.59
0
1,159.59
Raw Material Cost
611.26
0
611.26
Purchase of Finished goods
60.29
0
60.29
(Increase) / Decrease In Stocks
7.04
0
7.04
Employee Cost
189.38
0
189.38
Power Cost
0.00
0
0.00
Manufacturing Expenses
-0.01
0
-0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
144.77
0.00
144.77
Total Expenditure (Excl Depreciation)
1,012.73
0
1,012.73
Operating Profit (PBDIT) excl Other Income
146.86
0.00
146.86
Other Income
34.33
0
34.33
Operating Profit (PBDIT)
181.19
0
181.19
Interest
23.74
0
23.74
Exceptional Items
-18.23
0
-18.23
Gross Profit (PBDT)
139.22
0
139.22
Depreciation
39.65
0
39.65
Profit Before Tax
99.57
0
99.57
Tax
31.89
0
31.89
Provisions and contingencies
0.00
0
0.00
Profit After Tax
67.67
0
67.67
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
67.67
0
67.67
Share in Profit of Associates
0.00
0
0.00
Minority Interest
1.36
0
1.36
Other related items
0.00
0.00
0.00
Consolidated Net Profit
66.32
0
66.32
Equity Capital
30.62
0
30.62
Face Value
2.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
4.33
0
4.33
Diluted Earnings per share
4.33
0
4.33
Operating Profit Margin (Excl OI)
12.66%
0%
0.00
12.66%
Gross Profit Margin
12.01%
0%
0.00
12.01%
PAT Margin
5.84%
0%
0.00
5.84%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,159.59 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is 13.96% vs -0.63% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 14.76% vs -6.69% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 66.32 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is 62.63% vs -35.76% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 1.75% vs -66.35% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 146.86 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is 55.46% vs -26.75% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 21.01% vs 29.88% in Dec 2024
Quarterly - Interest
Interest 23.74 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is 1.89% vs 0.69% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 362.77% vs -58.76% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.66%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
